Gilead Sciences GILD
NASDAQ GILD
$148.07 -0.98 (-0.66%)
As of: Oct 1, 2026 · 2:54 PM EDT

Gilead Sciences (GILD) Convertible Debt (2009 - 2010)

Updated

Gilead Sciences (GILD) posted Convertible Debt of $2.84 billion for Q4 2010, up 145.7% from $1.16 billion a year earlier and up 0.7% from the prior quarter.

Analysis

Gilead Sciences (GILD) Convertible Debt (2009 - 2010) Analysis & Trends

Since Q2 2009, Gilead Sciences has reported Convertible Debt for 6 quarters.

  • In prior years, Gilead Sciences' Convertible Debt was $1.16 billion in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Bristol Myers Squibb 127.55 Bn 78.82 Bn 9.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 2.84 Bn
Sep 30, 2010 2.82 Bn
Mar 31, 2010 1.17 Bn
Dec 31, 2009 1.16 Bn
Sep 30, 2009 1.14 Bn
Jun 30, 2009 1.13 Bn
API Access

Gilead Sciences Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=GILD&period=max&api_key=YOUR_API_KEY